Exchange: NASDAQ·Updated 05:46 AM EDT
JUNS logo

JUNS Jupiter Neurosciences Inc.

$3.33
$0.10
(2.92%)
Pre-Market
Prev Close $3.43
Mkt Cap$4.09M
Vol43.00

About JUNS

Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The firm offers JOTROL, an enhanced orally administered resveratrol formulation, designed to deliver therapeutically relevant, safe levels of resveratrol. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in January 2016 and is headquartered in Jupiter, FL.
40

Bearish Sentiment

How do you feel about JUNS?

Advertisement|Remove ads.